MENU
PYPD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

PolyPid (PYPD) Earnings Date & Reports

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more

A.I. Advisor
published Earnings

PYPD is expected to report earnings to rise 55.71% to -37 cents per share on February 10

PolyPid PYPD Stock Earnings Reports
Q4'26
Est.
$-0.37
Q3'26
Missed
by $0.70
Q2'26
Beat
by $0.05
Q1'26
Beat
by $0.70
Q4'25
Missed
by $0.08
The last earnings report on November 11 showed earnings per share of -23 cents, missing the estimate of 46 cents. With 137.84K shares outstanding, the current market capitalization sits at 124.71M.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
75
Web
https://www.polypid.com